Penicillin-clavulanate susceptibility in clinical MRSA bloodstream infection strains from the CAMERA2 trial
This study of MRSA bloodstream isolates from the CAMERA2 trial reveals that penicillin-clavulanate susceptibility is common (62%) and strongly predicted by oxacillin disk susceptibility and specific genetic backgrounds, including *mecA* alleles and community-associated lineages.